-
3 Month EMI Relief – Free MSME Registration & COVID Filing
Dear Client, We hope you are safe and staying at home during the lock down period. At our Consultancy, we are all working from home and continue to support our clients during this testing time. In an effort to help our customers further, we are offering FREE MSME Registration and MCA COVID-19 Compliance till 10th…
-
In view of the challenges faced by the outbreak of COVID-19
Corrigendum to Public Notice dated March 25, 2020). According to a public notice issued by the Head of IP Offices in India (Controller General of Patents, Designs, Trademarks, Geographical Indication and Copyright) all due dates for filing documents/replies, payment of fees, and completion of any action in respect of any IP application filed in India…
-
Taj Pharmaceuticals: We’re Taj Pharma, pleased to meet you! {Taj Pharma}
About Taj Pharmaceuticals Founded in 1985 by our Chairman of board of director Dr.Ranveer Kumar Singh, Taj Pharmaceuticals is one of the fastest growing pharmaceutical development and manufacturing companies in India. Outstanding customer service and the highest manufacturing standards have driven our success. Taj Pharma is consistently ranked as the top performer in Indian Pharma…
-
Most Conferences: Unveiling the Hidden Drain of Time, Money, and Effort
Introduction In the bustling world of professional events and conferences, the back row of seats often becomes the refuge for those seeking an escape from the monotonous routine that characterizes many business gatherings. As a seasoned professional speaker, I recently found myself deliberately positioning in that coveted back row at a conference in New Delhi.…
-
In Italy, Going Back to Work May Depend on Having the Right Antibodies
In Italy, Going Back to Work May Depend on Having the Right Antibodies #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus
-
Newest Developments in SARS-CoV-2 Research: Week of Sunday, April 26th 2020
Months into the unfolding coronavirus crisis, and four weeks into writing this blog, new research results are giving context to how the virus arrived in the first place. SARS-CoV-2 is a zoonotic virus, meaning it first emerged in an animal and, through a chain of transmission, infected humans.
-
What You Should Know About the Coronavirus Drug Under Study
How to read the data on hydroxychloroquine The Great Hydroxychloroquine Debate A 91.7% success rate with hydroxychloroquine and azithromycin — too good to be true? A critical review of the latest data.
-
404 Error, content does not exist anymore
metaseo_404_page
-
“There Is Hope for This Horrible Pandemic” – Trial Drug Can Block Early Stages of COVID-19
“There is hope for this horrible pandemic,” says University of British Columbia scientist Dr. Josef Penninger. The study provides new insights into key aspects of SARS-CoV-2, the virus that causes COVID-19, and its interactions on a cellular level, as well as how the virus can infect blood vessels and kidneys.
-
The Unpredictable Curve of COVID-19
Expanding our mental model of flattening the curve to make sense of the uncertain road ahead. The infographic version of “flatten the curve” has been reinterpreted a number of ways (including with cats and baby Yoda). Most iterations are conceptual graphics though, not rooted in the actual case counts of COVID-19. Opinion articles have proliferated,…